Wellington Management Group LLP Bausch Health Companies Inc. Transaction History

Wellington Management Group LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $819 - $1,648	179 Added 0.09%	191,476 $1.32 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $1.35 Million - $4.52 Million	191,297 New	191,297 $1.6 Million
Q4 2020 Feb 12, 2021	SELL	$15.31 - $21.12 $10.7 Million - $14.8 Million	-701,208 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $10.4 Million - $14.1 Million	701,208 New	701,208 $10.9 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $57.8 Million - $89 Million	-4,340,376 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$12.98 - $30.25 $39.2 Million - $91.4 Million	3,020,889 Added 228.94%	4,340,376 $67.3 Million
Q4 2019 Feb 11, 2020	BUY	$18.89 - $31.89 $24.9 Million - $42.1 Million	1,319,487 New	1,319,487 $39.5 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.